The formation and stability of imidazolidinone adducts from acetaldehyde and model peptides: A kinetic study with implications for protein modification in alcohol abuse

Biochemical Pharmacology

Volumn 51, Issue 10, 1996, Pages 1259-1267

  Fowles, Lindsay F ^a   Beck, Eleanor ^a   Worrall, Simon ^a   Shanley, Brian C ^a   De Jersey, John ^a  

^a NONE

Author keywords

Acetaldehyde; Alcohol abuse; Amino groups; Imidazolidinone adducts; Modified proteins in alcoholism; Peptides

Indexed keywords

ACETALDEHYDE; DIPEPTIDE; IMIDAZOLIDINONE; TRIPEPTIDE; UNCLASSIFIED DRUG;

ALCOHOLISM; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; LIVER; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TEMPERATURE;

ACETALDEHYDE; DRUG STABILITY; IMIDAZOLES; KINETICS; PEPTIDES; TEMPERATURE; TIME FACTORS;

EID: 0029879805     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(95)02408-5     Document Type: Article

References (39)

1. Stevens VJ, Fantl WJ, Newman CG, Sims RV, Cerami A and Peterson CM, Acetaldehyde adducts with haemoglobin. J Clin Invest 67: 361-369, 1981.
2. Sorrell MF and Tuma DJ, The functional implications of acetaldehyde binding to cell constituents. Ann NY Acad Sci 492: 50-62, 1987.
3. McKinnon G, de Jersey J, Shanley B and Ward L, The reaction of acetaldehyde with brain microtubular proteins: formation of stable adducts and inhibition of polymerization. Neurosci Lett 79: 163-168, 1987.
4. San George RC and Hoberman HD, Reaction of acetaldehyde with hemoglobin. J Biol Chem 261: 6811-6821, 1986.
5. Hruby VJ, Yamashiro D and du Vigneaud V, The structure of acetone-oxytocin with studies on the reaction of acetone with various peptides. J Am Chem Soc 90: 7106-7110, 1968.
6. Summers MC, Structural and biological studies of the acetaldehyde adducts of enkephalins and related peptides: a short review. In: Aldehyde Adducts in Alcoholism, Progress in Clinical and Biological Research, Vol 183, (Ed. Collins MA), pp 30-49, Alan R. Liss, New York, 1985.
7. Gidley MJ, Hall LD, Sanders JKM and Summers MC, Acetaldehyde-enkephalins: structure proof and some conformational deductions from one- and two- dimensional proton nuclear magnetic resonance spectra. Biochemistry 20: 3880-3883, 1981.
8. Klixbüll U and Bundgaard H, Kinetics of reversible reactions of ampicillin with various aldehydes and ketones with formation of 4-imidazolidinones. Int J Pharm 23: 163-173, 1985.
9. Klixbüll U and Bundgaard H, 4-Imidazolidinones as potential bioreversible derivatives for the α-aminoamide moiety in peptides. Int J Pharm 20: 273-284, 1984.
10. 3-(2,6-dimethylphenyl)-4-imidazolidinone from the reaction of a metabolite of alcohol with a metabolite of lidocaine. J Med Chem 16: 1106-1112, 1973.
11. Summers MC and Lightman SL, A reaction of acetaldehyde with enkephalins and related peptides. Biochem Pharm 30: 1621-1627, 1981.
12. Fields R, The rapid determination of amino groups with TNBS. Methods Enzymol 25B: 464-468, 1972.
13. Bernt E and Bergmeyer H, Acetaldehyde determination with alcohol dehydrogenase from yeast. In: Methods in Enzymatic Analysis, Vol 3, (Ed. Bergmeyer H), pp. 1506-1509. Academic Press, New York, 1974.
14. Plapp BV, Moore S and Stein WH, Activity of bovine pancreatic deoxyribonuclease A with modified amino groups. J Biol Chem 246: 939-945, 1971.
15. Johnson LF and Jankowski WC, Carbon-13 NMR Spectra: A Collection of Assigned, Coded and Indexed Spectra. Wiley Intersciences, New York, 1972.
16. San George RC and Hoberman HD, Structure of stable acetaldehyde adducts of peptides and proteins: results of mass spectrometric analysis. Federation Proc 46: 1324, 1987.
17. Stockham TL and Blanke RV, Investigation of an acetaldehyde-hemoglobin adduct in alcoholics. Alcoholism Clin Exp Res 12: 748-754, 1988.
18. Driessen HPC, de Jong WW, Tesser GI and Bloemendal H, The mechanism of N-terminal acetylation of proteins. CRC Crit Rev Biochem 18: 281-325, 1983.
19. Nuutinen H, Lindros KO and Salaspuro M, Determinants of blood acetaldehyde level during ethanol oxidation in chronic alcoholics. Alcoholism Clin Exp Res 7: 163-166, 1983.
20. Baraona E, Di Padova C, Tabasco J and Lieber CS, Red blood cells: A new major modality for acetaldehyde transport from liver to other tissues. Life Sci 40: 253-258, 1987.
21. Watanabe A, Kobayashi J, Hobara N, Nakatsukasa H, Nagashima H and Fujimoto A, A report of unusually high blood ethanol and acetaldehyde levels in two surviving patients. Alcohol Clin Exp Res 9: 14-16, 1985.
22. Eriksson CJP and Fukunaga T, Human blood acetaldehyde (Update 1992). Alcohol Alcohol 27: Suppl 2, 9-26, 1992.
23. 1H-NMR spectroscopy. Int J Biochem 17: 471-478, 1985.
24. Lin RC, Lumeng L, Shahidi S, Kelly T and Pound DC, Protein-acetaldehyde adducts in serum of alcoholic patients. Alcohol Clin Exp Res 14: 438-443, 1990.
25. Niemëla O, Israel Y, Mizoi Y, Fukunaga T and Eriksson CJP, Hemoglobin-acetaldehyde adducts in human volunteers following acute ethanol ingestion. Alcohol Clin Exp Res 14: 838-841, 1990.
26. Niemëla O, Juvonen T and Parkkila S, Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption. J Clin Invest 87: 1367-1374, 1991.
27. Worrall S, deJersey J, Shanley BC and Wilce PA, Detection of stable acetaldehyde-modified proteins in the liver of ethanol-fed rats. Alcohol Alcohol 26: 437-444, 1991.
28. Xu DS, Jennett RB, Smith SL, Sorrell MF and Tuma DJ, Covalent interactions of acetaldehyde with the actin/microfilament system. Alcohol Alcohol 24: 281-289, 1989.
29. Jennett RB, Saffari-Fard A, Sorrell MF, Smith SL and Tuma DJ, Increased binding of acetaldehyde to calmodulin in the presence of calcium. Life Sci 45: 1461-1466, 1989.
30. Israel Y, Hurwitz E, Niemëla O and Arnon R, Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts. Proc Natl Acad Sci USA 83: 7923-7927, 1986.
31. Worrall S, de Jersey J, Shanley BC and Wilce PA, Ethanol induces the production of antibodies to acetaldehyde-modified epitopes in rats. Alcohol Alcohol 24: 217-233, 1989.
32. Niemëla O, Lajner F, Orrego H, Vidins E, Blendis L and Israel Y, Antibodies against acetaldehyde-modified protein epitopes in human alcoholics. Hepatology 7: 1210-1214, 1987.
33. Hoerner M, Behrens UJ, Worner TM, Blacksberg I, Braly LF, Schaffner F and Lieber CS, The role of alcoholism and liver disease in the appearance of serum antibodies to acetaldehyde adducts. Hepatology 8: 569-574, 1988.
34. Worrall S, de Jersey J, Shanley BC and Wilce PA, Antibodies against acetaldehyde-modified epitopes: Presence in alcoholic, non-alcoholic liver disease and control subjects. Alcohol Alcohol 25: 509-517, 1990.
35. Worrall S, de Jersey J, Shanley BC and Wilce PA, Antibodies to acetaldehyde-modified epitopes: an elevated immunoglobulin A response in alcoholics. Eur J Clin Invest 21: 90-95, 1991.
36. Worrall S, de Jersey J, Shanley BC and Wilce PA, Antiacetaldehyde adduct antibodies generated by ethanol-fed rats react with reduced and unreduced acetaldehyde-modified proteins. Alcohol Alcohol 29: 43-50, 1994.
37. Gross MD, Hays R, Gapstur SM, Chausee M and Potter JD, Evidence for the formation of multiple types of acetaldehyde-haemoglobin adducts. Alcohol Alcohol 29: 31-41, 1994.
38. Sillanaukee P, Seppa K, Koivula T, Israel Y and Niemëla O, Acetaldehyde-modified haemoglobin as a marker of alcohol consumption: comparison of two new methods. J Lab Clin Med 120: 42-47, 1992.
39. Lin RC, Shahidi S, Kelly TJ, Lumeng C and Lumeng L, Measurement of haemoglobin-acetaldehyde adduct in alcoholic patients. Alcohol Clin Exp Res 17: 669-674, 1993.